Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress

In conclusion, our findings suggest that the antitumor activity of LCL-SIM on B16.F10 melanoma growth is a result of the tumor-targeting property of the liposome formulation and is tightly dependent on the presence of TAM in tumor tissue.